trilaciclib
Description: Trilaciclib is a cyclin-dependent kinase 4/6 inhibitor used to protect bone marrow from chemotherapy-induced myelosuppression in cancer treatment.
Primary topic: Lung Cancer Research Studies (27%)
Wikidata ID: wiki/Q105592965
OpenAlex ID: keywords/trilaciclib
